BRIEF — BioArctic extends antibody collaboration with Uppsala University

Swedish biopharma BioArctic has signed an extended research collaboration agreement with Uppsala University’s Department of Pharmaceutical Biosciences.

The extended research collaboration concerns technologies for increased passage across the blood-brain barrier and BioArctic will contribute financial support for a three year post-doc research position.

Under an earlier collaboration with the university, BioArctic develops a technology that facilitates the passage of antibodies across the blood-brain barrier. This project is in research phase.

The new extended collaboration aims to develop innovative technologies to increase the passage of antibodies also into nerve cells. This can be of value for the diagnosis and treatment of neurodegenerative diseases such as Alzheimer's and Parkinson's disease.